|
日期: 2025-05-04
今日:
总计:
上次:
| |
|
|
|
| 1 | 10-脱乙酰巴卡丁III
| 10-Deacetyl Baccatin III
| ≥99%
|
| 2 | 10-羟基喜树碱
| 10-Hydroxycampotothecin
| ＞99%
|
| 3 | 甘草次酸
| 18-β-Glycyrrhetinic acid
| ≥98%
|
| 4 | 五羟基色胺酸
| 5-HTP
| ≥99%
|
| 5 | 穿心莲内脂
| Andrographolides
| ≥99%
|
| 6 | 熊果酚甙
| Arbutin
| ≥98%
|
| 7 | 积雪草甙
| Asisticoside
| ≥90%
|
| 8 | 黄芩甙
| Baicalin
| ＞98%
|
| 9 | 岩白菜素
| BERGENINUM
| 97%
|
| 10 | 灯盏花素
| Breviscapine
| 95%; 95% for injection
|
| 11 | 三尖杉宁碱
| Cephalomannine
| ≥98%
|
| 12 | 叶绿素铜钠盐
| Chlorophyll
(Sodium Copper Chlorophyllin)
| ≥99%
|
| 13 | 多烯紫杉醇
| Docetaxel
| ≥98%
|
| 14 | 蜕皮激素
| Ecdysterone
| ≥60% 20-Hydroxy-
β-Ecdysterone; 96% HPLC
|
| 15 | 黄藤素
| Fibrauetnum
| ≥95%; 95% for injection
|
| 16 | 漆黄素
| Fisetin
| ≥98%
|
| 17 | 染料木素
| Genistin
| ≥98%
|
| 18 | 银杏黄酮B
| Ginkgolide B
| ≥90% INJECTION
|
| 19 | 银杏酮
| Ginkgolides
| ≥95% INJECTION
|
| 20 | 甘草酸
| Glycyrrhizic acid
| ≥98%
|
| 21 | 昆明神衰果素
| Helicidum
| 95%
|
| 22 | 橙皮甙
| Hesperidin
| ≥98%
|
| 23 | 高三尖杉脂碱
| Homoharringtonine
| 98%
|
| 24 | 淫羊藿甙
| Icariin
| ≥98%
|
| 25 | 靛玉红
| Indirubin
| 90%
|
| 26 | 木犀草素
| Luteolin
| 98% UV
|
| 27 | 苦参碱
| Matrine
| ≥98%, ≥90% UV
|
| 28 | 三七总皂甙
| Notogisenosides
| Rb1＞30%, Rg1＞20%
R1＞5%, Tota1＞88%
|
| 29 | 氧化苦参碱
| Oxymatrine
| ≥98%
|
| 30 | 紫杉醇
| Paclitaxel
| ≥99%, ≥99.5%
|
| 31 | 三七叶提取物
| Panax Notoginseng Leaf P.E.
| Rb3＞85%
|
| 32 | 二十八碳醇
| Polycosanol
| 12%, 20%
|
| 33 | 葛根素
| Puerarin
| ≥97%
|
| 34 | 槲皮素
| Quercetin
| ＞98%
|
| 35 | 白藜芦醇
| Resveratrol
| ≥98%
|
| 36 | 钩藤碱
| Rhynchophylline
| ≥98%
|
| 37 | 冬凌草甲素
| Rubescensin A(Oridonin)
| ≥98%
|
| 38 | 芦丁
| RUTIN
| ≥99% DAB10, NF11
|
| 39 | 水杨甙
| Salicin
| 98.5%
|
| 40 | 莽草酸
| Shkikimic Acid
| ≥98%
|
| 41 | 青藤碱
| Sinomenine
| ≥95%
|
| 42 | 松萝酸钠
| Sodium Usini acid
| ≥99%
|
| 43 | 辛弗林
| Synephrine
| ≥98%
|
| 44 | 延胡索乙素（罗通定）
| Tetrahydropalmatine (Rotundine)
| ≥80%
|
| 45 | 茶黄素
| Theaflavins
| 40%
|
| 46 | 茶氨酸
| Theanine
| 30%
|
| 47 | 氨基葡萄糖盐酸盐
/硫酸盐
| D-Glucosamine HCL
/Sulfate Potassium Salt
| 99%
|
| 48 | 去氢表雄酮
| DHEA
| 99%
|
| 49 | 硫辛酸
| Alpha-Lipoic Acid
| 99%
|
| |
|
 |
|
 |
|
|
